OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy
Ze Mi, Qing Yao, Yan Qi, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 819-833
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Brain-Targeting Drug Delivery Systems: The State Of The Art In Treatment Of Glioblastoma
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 2

Image‐Guided Photothermal and Immune Therapy of Tumors via Melanin‐Producing Genetically Engineered Bacteria
Weijian Song, Yaling He, Ya‐Nan Feng, et al.
Small (2024) Vol. 20, Iss. 26
Open Access | Times Cited: 13

Mitophagy and cGAS–STING crosstalk in neuroinflammation
Xiaogang Zhou, Jing Wang, Lu Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3327-3361
Open Access | Times Cited: 12

Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy
Yufan Xiang, Bing Wang, Wanchun Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 9

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy
Zaigang Zhou, Wenjuan Luo, Chunjuan Zheng, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4087-4101
Open Access | Times Cited: 8

Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8

Nano/genetically engineered cells for immunotherapy
Jingrui Shen, Yang Zhou, Lichen Yin
BMEMat (2024)
Open Access | Times Cited: 8

Harnessing bacteria for tumor therapy: Current advances and challenges
Lina Guo, Jinsong Ding, Wenhu Zhou
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108557-108557
Closed Access | Times Cited: 16

Converting bacteria into autologous tumor vaccine via surface biomineralization of calcium carbonate for enhanced immunotherapy
Lina Guo, Jinsong Ding, Wenhu Zhou
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 12, pp. 5074-5090
Open Access | Times Cited: 16

Engineered bacterial extracellular vesicles for central nervous system diseases
Ning Ji, Fuxiao Wang, Miaomiao Wang, et al.
Journal of Controlled Release (2023) Vol. 364, pp. 46-60
Closed Access | Times Cited: 16

Neutrophil hitchhiking for nanoparticle delivery to the central nervous system
Qingshan Liu, Xuyan Li, Yili Wang, et al.
Applied Materials Today (2024) Vol. 38, pp. 102259-102259
Closed Access | Times Cited: 6

An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery
Francesca Susa, Silvia Arpicco, Candido Fabrizio Pirri, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 849-849
Open Access | Times Cited: 6

Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy
Shan Lu, Ze Mi, Peng Liu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Bacteria and Bacterial Components as Natural Bio-Nanocarriers for Drug and Gene Delivery Systems in Cancer Therapy
Rui Zong, Hainan Ruan, Chan‐Min Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2490-2490
Open Access | Times Cited: 15

Engineering Versatile Bacteria‐Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy
Ziheng Luo, Cheng Xiang, Bin Feng, et al.
Advanced Science (2024) Vol. 11, Iss. 33
Open Access | Times Cited: 5

Engineered Salmonella inhibits GPX4 expression and induces ferroptosis to suppress glioma growth in vitro and in vivo
Jiawen Chen, Ting Li, Nan Zhou, et al.
Journal of Neuro-Oncology (2023) Vol. 163, Iss. 3, pp. 607-622
Closed Access | Times Cited: 11

Synthesis and Characterization of ZIF-90 Nanoparticles as Potential Brain Cancer Therapy
Lorenzo Monarca, Francesco Ragonese, Paola Sabbatini, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 414-414
Open Access | Times Cited: 4

Innovative design of bacterial outer membrane vesicles for vaccine development
Qinzhen Cheng, Gaoli Niu, Yiling He, et al.
Nano Today (2025) Vol. 61, pp. 102650-102650
Closed Access

Confrontation of the ambivalent roles of the intestinal microbiota in carcinogenesis: Oncogenic or anticancer agents?
Fatouma Mohamed Abdoul‐Latif, Ayoub Ainane, Omaima Saoudi, et al.
Journal Of Advanced Pharmacy Education And Research (2025) Vol. 15, Iss. 2, pp. 16-30
Closed Access

Iron oxide based magnetic nanoparticles for hyperthermia, MRI and drug delivery applications: a review
Rizwana Ghazi, Talib K. Ibrahim, Jamal Abdul Nasir, et al.
RSC Advances (2025) Vol. 15, Iss. 15, pp. 11587-11616
Open Access

Bacterial extracellular vesicles – brain invaders? A systematic review
Anna Kaisanlahti, Sonja Salmi, Sohvi Kumpula, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7

Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy
İrem Karaman, Asmita Pathak, Defne Bayık, et al.
Pathogens and Immunity (2024) Vol. 9, Iss. 1, pp. 56-90
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top